Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

HAM/T9G stock hub

HAM/T9G has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HAM/T9Gis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

31.7M

Hamburg Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

HAM/T9G

In the news

Latest news · HAM/T9G

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROICn/a

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HAM/T9G market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

Groups with data

Currency

EUR

Showing 71 of 71 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	DE
Exchange	Hamburg Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 31.7M
Price	EUR 0.57
Price currency	EUR
Sic	2836
Symbol	ham/T9G
Website	https://www.vidacpharma.com

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-2.07%
Cagr3y	-20.95%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-2.07%
200-day SMA	0.41
3Y total return	-50.61%
50-day SMA	0.54
50-day SMA vs 200-day SMA	50over200
All Time High	1.63
All Time High Change	-65.15%
All Time High Date	2023-08-04
All Time Low	0.18
All Time Low Change	219.1%
All Time Low Date	2024-06-12
ATR	0.05
Ch YTD	-0.35
High	0.57
High52	0.8
High52 Date	2026-03-09
High52ch	-29%
Low	0.57
Low52	0.45
Low52 Date	2025-09-23
Low52ch	26.22%
Ma50ch	4.82%
Price vs 200-day SMA	37.3%
RSI	51.74
RSI Monthly	46.73
RSI Weekly	53.31
Sharpe ratio	0.4x
Sortino ratio	0.86
Tr YTD	-0.35
Tr1m	-29%
Tr1w	3.27%
Tr3m	-0.35%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	4,031.5x
Ch1m	-29
Ch1w	3.27
Ch1y	-2.07
Ch3m	-0.35
Ch3y	-50.61
Ch6m	9.23
Change	0%
Change From Open	0
Dollar Volume	113.6
Earnings Date	2026-06-30
F Score	0
Founded	2,021
Is Primary Listing	0
Ma150	0.48
Ma150ch	18.41%
Ma20	0.53
Ma20ch	6.97%
Next Earnings Date	2026-06-30
Open	0.57
Price Date	2026-05-07
Relative Volume	0.05x
Tr6m	9.23%
Volume	200

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does HAM/T9G pay a dividend?

Capital-return profile for this ticker.

Performance

HAM/T9G stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Technical

HAM/T9G momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

51.7

Neutral momentum band

Price vs 200-day MA

+37.3%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.40

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HAM/T9G

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ham/T9G stock rating?

ham/T9G is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ham/T9G analysis?

The full report lives at /stocks/ham/T9G/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ham/T9G?

The latest report frames ham/T9G around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ham/T9G page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.